CK2B Induces CD8+ T‐Cell Exhaustion through HDAC8‐Mediated Epigenetic Reprogramming to Limit the Efficacy of Anti‐PD‐1 Therapy in Non‐Small‐Cell Lung Cancer.

Saved in:
Bibliographic Details
Title: CK2B Induces CD8+ T‐Cell Exhaustion through HDAC8‐Mediated Epigenetic Reprogramming to Limit the Efficacy of Anti‐PD‐1 Therapy in Non‐Small‐Cell Lung Cancer.
Authors: Liu, Shaochuan1,2,3,4,5,6 (AUTHOR), Ma, Shiya1,2,3,4,5,7 (AUTHOR), Liu, Gen1,2,3,4,5,7 (AUTHOR), Hou, Lingjie8 (AUTHOR), Guan, Yong1,2,3,4,6 (AUTHOR), Liu, Liang1,2,3,4,5,7 (AUTHOR), Meng, Yuan1,2,3,4,5,7 (AUTHOR), Yu, Wenwen1,2,3,4,5,7 (AUTHOR), Liu, Ting1,2,3,4,5,7 (AUTHOR), Zhou, Li1,2,3,4,5,7 (AUTHOR), Yuan, Zhiyong1,2,3,4,6 (AUTHOR), Pang, Shuju1,2,3,4,5,7 (AUTHOR), Zhang, Siyuan1,2,3,4,5,7 (AUTHOR), Li, Junyi1,2,3,4,6 (AUTHOR), Ren, Xiubao1,2,3,4,5,7 (AUTHOR) renxiubao@tjmuch.com, Sun, Qian1,2,3,4,5,7 (AUTHOR) sunqian@tjmuch.com
Source: Advanced Science. 4/24/2025, Vol. 12 Issue 16, p1-20. 20p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21983844
DOI:10.1002/advs.202411053